Decision/Conclude agreement
Proposed

泰格醫藥通過全資附屬香港泰格參與方達控股私有化及業務分拆

Tigermed will use its wholly owned Hong Kong subsidiary to take part in the privatization and business split of Frontage Holdings, a move UBS says may help it focus on core clinical CRO services.

Trajectories

Sign-in readers can mine up to three arcs for this record.

Sign in to get trajectories

Actors and targets

Targets 方達控股actor私有化及業務分拆transaction

Source

泰格醫藥宣布將通過全資附屬香港泰格,參與方達控股(01521)私有化及業務分拆。
stockintelligencenews · Telegram Open post

Not established

  • Announcement date
  • Expected completion date
  • Total transaction value

Extracted detail

Related decisions

Same kind only, ranked by embedding similarity to this record.